CLEC4D (CLECSF8), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-CLEC4D (CLECSF8), Human antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CLEC4D (CLECSF8), Human |
| Clone | REA757 |
| Host Species | Recombinant Human |
| Reactive Species | human |
| Isotype | IgG1 |
| Format | biotin conjugate |
| Size | 100 tests in 200 µL |
| Concentration | 1:50 |
| Applications | Flow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CLEC4D (CLECSF8) Antibody, anti-human, Biotin, REAfinity™. Clone REA757 recognizes the human CLEC4D antigen, a cell-surface receptor that belongs to the human calcium-dependent lectin family (C-type lectin), also known as CLECSF8, CLEC-6, or MCL. CLEC4D is expressed in a low level in peripheral blood leukocytes, in bone marrow, and spleen. It is mainly found in monocytes and macrophage and seems to be up-regulated by IL-6, IL-10, TNF-α, and IFN-γ. | Additional information: Clone REA757 displays negligible binding to Fc receptors. |
| Immunogen | n/a |
| Other Names | CLECSF8, MCL, CLEC-6 |
| Gene, Accession # | Gene ID: 338339 |
| Catalog # | 130-110-720 |
| Price | $264 |
| Order / More Info | CLEC4D (CLECSF8), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Arce, I. et al. (2004) The human C-type lectin CLECSF8 is a novel monocyte/macrophage endocytic receptor. Eur. J. Immunol. 34 (1): 210-220. | Flornes, L. M. et al. (2004) Identification of lectin-like receptors expressed by antigen presenting cells and neutrophils and their mapping to a novel gene complex. Immunogenetics 56 (7): 506-517. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies